RalphS.FreedmanMD
Obstetrics & Gynecology • Houston, TXGeneral Gynecology, Gynecologic Oncology
Physician
Dr. Freedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
N/A
Houston, TX 77030
Education & Training
University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 1976 - 1976
University of the WitwatersrandClass of 1965
Certifications & Licensure
FL State Medical License 2018 - 2026
TX State Medical License 1977 - 2020- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer Start of enrollment: 1997 Oct 01
- Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer Start of enrollment: 2003 Jan 01
Publications & Presentations
PubMed
- 50 citationsImmunology of the peritoneal cavity: relevance for host-tumor relationBohuslav Melichar, Ralph S. Freedman
International Journal of Gynecological Cancer. 2002-01-01 - 49 citationsTreatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide.D.M. Gershenson, Larry J. Copeland, John J. Kavanagh, Ayten Cangir, Gerard Del Junco
Cancer. 1985-12-15 - 24 citationsISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer ProgressionTsz-Lun Yeung, Ching Chou Tsai, Cecilia S. Leung, Chi-Lam Au Yeung, Melissa S. Thompson
Cancers. 2018-11-22
Grant Support
- Autologous Therapeutic Tumor Vaccine + Ifn-GammaNational Center For Research Resources2004
- Phase II Intraperitoneal Rhil 12National Cancer Institute2001–2002
- B7.1 Costimulation In Ovarian CancerNational Cancer Institute2000–2001
- Autologous Therapeutic Tumor Vaccine + IFN Gamma In Ovarian CancerNational Center For Research Resources1999–2000
- IP Priming With Rifng And RIL 2 In IP Adoptive Immunotherapy Of Ovarian CancerNational Center For Research Resources1996–1999
- Ovarian Carcinoma TIL Treatment After IFN Gamma/Il2National Cancer Institute1994–1997
Professional Memberships
- Life Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
